Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Metropolis HealthcareNSE:METROPOLIS -0.25%91 Days Inventory is 44.43 as of Jun. 2026, which is 7% below its 10-year median of 47.76. GuruFocus rates NSE:METROPOLIS with a GF Score™ of 91/100 and a GF Value™ of ₹598.81 (Fairly Valued). The stock has 4 warning signs investors should review. Among 177 Medical Diagnostics & Research companies, Metropolis Healthcare ranks better than 63.84% on this metric.
The historical rank and industry rank for Metropolis Healthcare's Days Inventory or its related term are showing as below:
NSE:METROPOLIS'
s Days Inventory Range Over the Past 10 Years
Min: 38.65 Med: 47.76 Max: 66.23
Current: 46.5
During the past 11 years, Metropolis Healthcare's highest Days Inventory was 66.23. The lowest was 38.65. And the median was 47.76.
NSE:METROPOLIS's Days Inventory is ranked better than 63.84% of 177
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.64
vs NSE:METROPOLIS: 46.50
Metropolis Healthcare's Days Inventory
declined
from Jun. 2025 (51.53) to Jun. 2026 (44.43).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Metropolis Healthcare's Inventory Turnover for the
three
months ended in Jun. 2026 was 2.05.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Metropolis Healthcare's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.10.
Metropolis Healthcare (NSE:METROPOLIS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Metropolis Healthcare's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Metropolis Healthcare's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Metropolis Healthcare Days Inventory Related Terms
Metropolis Healthcare Days Inventory Historical Data
* Premium members only.
The historical data trend for Metropolis Healthcare's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:METROPOLIS vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Metropolis Healthcare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metropolis Healthcare Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Metropolis Healthcare's Days Inventory distribution charts can be found below:
* The bar in red indicates where Metropolis Healthcare's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metropolis Healthcare (NSE:METROPOLIS) has a Days Inventory of 44.43 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Metropolis Healthcare and its competitors. This is near median its historical median of 47.76. Over the past decade, Metropolis Healthcare's Days Inventory has ranged from 38.65 to 66.23. According to the industry distribution chart, Metropolis Healthcare ranks #64 out of 177 companies in the Medical Diagnostics & Research industry, placing it in the top 36.2%.
Is Metropolis Healthcare's Days Inventory too high?
Metropolis Healthcare's current Days Inventory of 44.43 is near median its 10-year median of 47.76. Over the past 10 years, this metric has ranged from a low of 38.65 to a high of 66.23. The Medical Diagnostics & Research industry median Days Inventory is 67.64. Metropolis Healthcare's value of 44.43 is 34.3% below this industry median. Based on the distribution chart, Metropolis Healthcare ranks #64 out of 177 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Metropolis Healthcare has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Metropolis Healthcare's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Metropolis Healthcare ranks #64 out of 177 companies for Days Inventory. This puts Metropolis Healthcare in the upper half of its industry. The industry median Days Inventory is 67.64. Metropolis Healthcare's value of 44.43 is 34.3% below this benchmark. Historically, Metropolis Healthcare's own Days Inventory has ranged from 38.65 to 66.23 over the past decade. While the company's 10-year median is 47.76 vs. the industry median of 67.64, Metropolis Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 67.64, based on 177 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metropolis Healthcare's current Days Inventory of 44.43 is 34.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Metropolis Healthcare and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 67.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metropolis Healthcare's current Days Inventory is 44.43, which is near median its own 10-year median of 47.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metropolis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Metropolis Healthcare (NSE:METROPOLIS) is currently considered Fairly Valued. The stock's GF Value™ is ₹598.81, compared to a current price of ₹563.20 — trading 5.9% below its estimated fair value. The current Days Inventory is 44.43, which is near median its 10-year median of 47.76 and 34.3% below the Medical Diagnostics & Research industry median of 67.64. Metropolis Healthcare's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Metropolis Healthcare (NSE:METROPOLIS), the current Days Inventory is 44.43 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metropolis Healthcare (NSE:METROPOLIS) Overvalued in 2026?
Based on GuruFocus' analysis, Metropolis Healthcare stock appears to be undervalued.
The current stock price of ₹563.20 is trading 5.9% below its estimated GF Value™ of ₹598.81.
GuruFocus considers Metropolis Healthcare to be Fairly Valued.
Key valuation signals for NSE:METROPOLIS:
Days Inventory: 44.43 (near median its 10-year median of 47.76)
GF Value™: ₹598.81 vs. price of ₹563.20 (5.9% below fair value)
Industry Position: 34.3% below the Medical Diagnostics & Research median (#64 of 177)
No single metric tells the full story. See the NSE:METROPOLIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.
91GF Score
Get the complete analysis for NSE:METROPOLIS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:METROPOLIS has been successfully added to your 
